ClinicalTrials.Veeva

Menu

Tonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial

Medical University of Vienna logo

Medical University of Vienna

Status

Completed

Conditions

Postoperative Pain
Hemorrhage
Otorhinolaryngologic Diseases
Postoperative Hemorrhage
Handling
Surgery--Complications
Tonsillectomy
Tonsillitis Chronic

Treatments

Device: BiZactTM Open Sealer/Divider

Study type

Interventional

Funder types

Other

Identifiers

NCT03793816
EK Nr: 1399/2018

Details and patient eligibility

About

Tonsillectomies are frequently followed by severe postoperative pain, hence high analgetics consumption and prolonged hospitalization. Also, postoperative hemorrhages can be hazardous. Constant evaluation of surgical techniques is paramount to improve safety and cost-effectiveness. Frequently tonsillectomies are performed in cold steel technique. Aim of this study will be the evaluation of handling, surgical time, postoperative pain and postoperative hemorrhage rates using the BiZactTM-Device in comparison to traditional techniques on the contralateral side. In one patient, two different techniques will be used.

The primary objective will be the surgical time. Regardless of surgeon handedness, surgeons will randomly be assigned to either start with the left or right tonsil, and randomly either to start with the BiZact™ Device or with "cold steel" methods.

Additionally, time to stop bleeding, intraoperative blood loss, tonsil mobility, device handling, as well as wound healing will be assessed.

Full description

Although stricter indication criteria have been implanted (especially in Austria since 2008), tonsillectomies are still performed very frequently. Post-surgical bleeding can potentially be life-threatening, and occur within 3 weeks after tonsillectomy. A broad survey in Great Britain revealed a postoperative hemorrhage rate in 33.921 patients between 1.5 and 5.4 %, varying on hospital size. Small collectives also showed rates up to 21.7%.

Worldwide, different techniques are used. Generally, "cold" steel and "hot" techniques can be distinguished, although often current-carrying ("hot") and "cold" instruments are used alternately. Postoperative pain seems to be uninfluenced by technique, whereas postoperative hemorrhage rates seem to be higher in "hot" techniques.

LigaSure® is a bipolar "current-carrying" device, which is able to seal vessels. Simultaneously tissue impedance is measured to control energy application. In this way only the required energy levels are applied. Therefore LigaSure® can also be referred as a "softened hot" technique.

In 2005 Lachanas et al. compared the LigaSure®-technique with the "cold" steel technique in 200 patients and found significantly less postoperative pain in favor of the LigaSure®-technique. Postoperative hemorrhage rates were not higher with LigaSure®. Based on the LigaSure®-scissors, Medtronic introduced a device specifically developed and licensed for tonsillectomies (BiZactTM).

Aim of this study will be the evaluation of handling, surgical time, postoperative pain and postoperative hemorrhage rates in comparison to traditional techniques on the contralateral side. In one patient, two different techniques will be used. This side-controlled evaluation of surgical techniques in tonsillectomies has been proven successfully in previous studies.

Enrollment

48 patients

Sex

All

Ages

14 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 14 and older
  • Written informed consent (in case of underage participant also parental informed consent)
  • Assigned for Tonsillectomy on both sides due to chronic tonsillitis

Exclusion criteria

  • History of abscesses in tonsillar region
  • Coagulation disorder (as assessed by a coagulation questionnaire and blood results)
  • Suspicion of untreated malignancy of any kind
  • Planned removal of only one tonsil

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

48 participants in 2 patient groups

BiZact™ device
Active Comparator group
Description:
BiZact™ device will be used appropriately to its purpose to remove one tonsil by: * Incision of the anterior palatal arch * Locating of the cranial pole of the tonsil * Dissection of the tonsil capsule * Localized coagulation of bleeding vessels * Detaching of the inferior pole from the pharynx tissue
Treatment:
Device: BiZactTM Open Sealer/Divider
Cold steel dissection (CD)
Active Comparator group
Description:
Cold steel dissection (CD) with localized cauterization for hemostasis serves as the comparative procedure within each patient (cross-over).
Treatment:
Device: BiZactTM Open Sealer/Divider

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems